| |
|
Partnering With Us
Partners can access ActiveSight's expertise in Fragment-based Lead Discovery (FBLD) at different stages of the Drug Development process towards the goal of obtaining novel leads that are more likely to succeed in the clinic. By leveraging ActiveSight's LENS™ Technology, Partners can benefit from cutting-edge FBLD technologies without the capital expenditure normally required. The schematic below outlines the breadth of ActiveSight's expertise, please see the Capabilities page for more information.
|
|
| |
| ActiveSight is the preferred partner for FBLD
Why work with ActiveSight? A successful Lead Discovery project requires the expertise
and commitment that can only be provided by scientists who have extensive experience with difficult drug targets
and a passion for curing disease. ActiveSight's assets and advantages include:
- Leading-edge scientists with over 40 years experience in FBLD, HT-crystallography and drug discovery
- Identification and development of new technologies to take FBLD to the next level
- Flexible business model and target options
- Dedicated and experienced Project Management team to advance your lead compound to pre-IND stage
|
| Improve Your Lead Discovery Outlook
By partnering with us, you'll be able to introduce high quality leads into
your pipeline quickly, and at a fraction of the cost needed to set up FBLD infrastructure. Contact us
to schedule a visit or a web-based presentation. |
